3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow sonelokimab: new trials by email Literature Review of sonelokimab trials Research Report on sonelokimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis Sonelokimab, Placebo, Adalimumab - Arthritis, Psoriatic | Phase 2 | Completed | MoonLake Immunotherapeutics AG | 207 | 2022-12-13 | 2026-09-10 |
| Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa Sonelokimab (M1095), Adalimumab, Placebo - Hidradenitis Suppurativa | Phase 2 | Completed | MoonLake Immunotherapeutics AG | 234 | 2022-04-25 | 2026-09-09 |
| A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis M1095 (Sonelokimab), Placebo, Secukinumab - Psoriasis | Phase 2 | Completed | Bond Avillion 2 Development LP | 313 | 2018-07-31 | 2021-08-03 |
Psoriasis (2) · Skin Diseases (2) · Arthritis (1) · Arthritis, Psoriatic (1) · Folliculitis (1) · Hidradenitis (1) · Hidradenitis Suppurativa (1) · Joint Diseases (1) · Skin Diseases, Bacterial (1) · Suppuration (1) · Sweat Gland Diseases (1)
MoonLake Immunotherapeutics AG (2) · Bond Avillion 2 Development LP (1)
Bulgaria (3) · Germany (3) · Poland (3) · United States (3) · Canada (2) · Czechia (2) · Hungary (2) · Estonia (1) · Ireland (1) · Netherlands (1) · Spain (1)
Dr. Kim Papp (1)